A detailed history of Alliancebernstein L.P. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 151,724 shares of DVAX stock, worth $1.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
151,724
Previous 165,649 8.41%
Holding current value
$1.95 Million
Previous $1.86 Million 9.14%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.05 - $11.61 $139,946 - $161,669
-13,925 Reduced 8.41%
151,724 $1.69 Million
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $218,419 - $256,078
20,356 Added 14.01%
165,649 $1.86 Million
Q1 2024

May 14, 2024

SELL
$11.7 - $14.98 $188,136 - $240,878
-16,080 Reduced 9.96%
145,293 $1.8 Million
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $269,130 - $307,988
20,560 Added 14.6%
161,373 $2.26 Million
Q2 2023

Aug 15, 2023

BUY
$9.85 - $13.17 $159,176 - $212,827
16,160 Added 12.96%
140,813 $1.82 Million
Q1 2023

May 15, 2023

SELL
$9.44 - $11.88 $165,313 - $208,042
-17,512 Reduced 12.32%
124,653 $1.22 Million
Q4 2022

Feb 14, 2023

BUY
$10.27 - $13.29 $2,629 - $3,402
256 Added 0.18%
142,165 $1.51 Million
Q3 2022

Nov 15, 2022

BUY
$9.93 - $17.44 $1,737 - $3,052
175 Added 0.12%
141,909 $1.48 Million
Q2 2022

Aug 15, 2022

BUY
$7.45 - $12.83 $186,130 - $320,544
24,984 Added 21.4%
141,734 $1.78 Million
Q1 2022

May 13, 2022

BUY
$9.75 - $14.44 $2,925 - $4,332
300 Added 0.26%
116,750 $1.27 Million
Q1 2021

May 06, 2021

BUY
$4.57 - $11.18 $147,154 - $359,996
32,200 Added 38.22%
116,450 $1.15 Million
Q4 2020

Feb 08, 2021

SELL
$3.73 - $5.6 $109,289 - $164,080
-29,300 Reduced 25.8%
84,250 $375,000
Q3 2020

Nov 12, 2020

SELL
$4.32 - $11.7 $10,368 - $28,080
-2,400 Reduced 2.07%
113,550 $491,000
Q2 2020

Aug 13, 2020

SELL
$2.94 - $9.1 $26,665 - $82,537
-9,070 Reduced 7.25%
115,950 $1.03 Million
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $174,105 - $376,353
47,700 Added 61.69%
125,020 $499,000
Q2 2018

Aug 13, 2018

BUY
$15.15 - $20.75 $36,360 - $49,800
2,400 Added 3.2%
77,320 $1.18 Million
Q4 2017

Feb 13, 2018

SELL
$17.3 - $24.08 $975,201 - $1.36 Million
-56,370 Reduced 42.94%
74,920 $1.4 Million
Q3 2017

Nov 13, 2017

BUY
$15.2 - $21.5 $2 Million - $2.82 Million
131,290
131,290 $2.82 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.